ALBO - アルビレオ・ファ―マ (Albireo Pharma Inc.) アルビレオ・ファ―マ

 ALBOのチャート


 ALBOの企業情報

symbol ALBO
会社名 Albireo Pharma Inc (アルビレオ・ファ―マ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 アルビレオ・ファーマ(Albireo Pharma Inc.)(旧名:Biodel Inc.)は臨床段階の生物製薬会社である。同社は孤児小児肝疾患及び他の肝臓・胃腸の疾患と障害を治療するための胆汁酸モジュレーターの開発・商業化に従事する。臨床パイプラインは2つ以上の第II相製品候補と1つの第III相製品候補を含む。同社のパイプラインはA4250、A3384及びElobixibatを含む。A4250は進行性家族肝内胆汁うっ滞(PFIC)等の小児孤児胆汁うっ滞性肝疾患の治療方法として開発される。A3384は胆汁酸吸収不良(BAM)疾患を治療するために開発される。また、Elobixibatは慢性特発性便秘(CIC)を治療するために開発される。A4250とElobixibatは回腸胆汁酸トランスポーター(IBAT)の選択的阻害剤である。同社は19以上のBAM被験者を対象として、A3384のプロトタイプの第II相臨床試験を完了した。   アルビレオ・ファ―マは米国のバイオ医薬品メ―カ―。主に、糖尿病や骨粗しょう症などの内分泌障害 治療薬の開発と商品化に注力する。高分子量のインスリン吸収時間を速くする研究を行っており、超速効型インスリン「BIOD-123」や「BIOD531」を開発中。本社所在地はコネチカット州ダンバリ―。   Albireo Pharma, Inc. engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. It pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.
本社所在地 10 Post Office Square Suite 502 South Boston MA 02109 USA
代表者氏名 David Chiswell デビッドチスウェル
代表者役職名 Independent Chairman of the Board
電話番号 +1 857-415-4774
設立年月日 37956
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 22人
url www.albireopharma.com
nasdaq_url https://www.nasdaq.com/symbol/albo
adr_tso
EBITDA EBITDA(百万ドル) -22.81400
終値(lastsale) 30.01
時価総額(marketcap) 359217539.28
時価総額 時価総額(百万ドル) 367.47680
売上高 売上高(百万ドル) 11.93100
企業価値(EV) 企業価値(EV)(百万ドル) 184.24880
当期純利益 当期純利益(百万ドル) -27.78900
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Albireo Pharma Inc revenues increased from $2K to $11.9M. Net loss increased 26% to $16.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and development increase from $5.8M to $12.6M (expense) General and administrative increase from $3.7M to $8.4M (expense) Non-operating income (expense).

 ALBOのテクニカル分析


 ALBOのニュース

   Cramer Gives His Opinion On Cloudera, Barrick Gold And More  2020/10/20 09:03:00 Benzinga
On CNBC's "Mad Money Lightning Round," Jim Cramer said Zuora Inc (NYSE: ZUO) is struggling because it has real competition. Albireo Pharma Inc …
   The Daily Biotech Pulse: AstraZeneca Pauses Coronavirus Vaccine Study, Trillium To Get $25M Pfizer Investment  2020/09/09 11:23:14 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Akouos Inc (NASDAQ: AKUS ) Albireo Pharma Inc (NASDAQ: ALB )(announced positive Phase 3 results for odevixibat in a liver disorder called progressive familial intrahepatic cholestasis) Castle Biosciences Inc (NASDAQ: CSTL ) Harmony Biosciences Holdings Inc (NASDAQ: HRMY ) Kura Oncology Inc (NASDAQ: KURA ) Merit Medical Systems, Inc. (NASDAQ: MMSI )(announced sale of manufacturing equipment and associated assets used in its hypotube manufacturing business) X T L Biopharmaceuticals Ltd (NASDAQ: XTLB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 8) ADiTx Therapeutics Inc (NASDAQ: ADTX ) AEterna Zentaris Inc. (NASDAQ: AEZS )(announced the presentation of data from pediatric study of macimorelin for childhood-onset growth hormone deficiency) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) Ayala Pharmaceuticals Inc (NASDAQ: AYLA ) Burning Rock Biotech Ltd (NASDAQ: BNR ) Checkmate Pharmaceuticals Inc (NASDAQ: CMPI ) Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP )( reacted to a negative data readout) Immatics NV (NASDAQ: IMTX ) Kymera Therapeutics Inc (NASDAQ: KYMR ) Legend Biotech Corp (NASDAQ: LEGN ) Regulus Therapeutics Inc (NASDAQ: RGLS ) Royalty Pharma plc (NASDAQ: RPRX ) Second Sight Medical Products Inc (NASDAQ: EYES ) Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS ) Viveve Medical Inc (NASDAQ: VIVE ) Stocks In Focus AstraZeneca Halts Coronavirus Vaccine Study to Allow For Safety Review Following an Unexplained Illness AstraZeneca plc (NYSE: AZN ) shares are under pressure after the company said in a statement to STATNews it has voluntarily paused the study of the coronavirus vaccine candidate it is jointly developing with the Oxford University in order to allow review of safety data by an independent committee.
   32 Stocks Moving in Tuesday's Pre-Market Session  2020/09/08 11:12:58 Benzinga
Gainers Albireo Pharma, Inc. (NASDAQ: ALBO ) rose 66.2% … Full story available on Benzinga.com
   The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings  2020/03/13 11:52:53 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo Corporation (NASDAQ: MASI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 12.) Abbott Laboratories (NYSE: ABT ) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Aileron Therapeutics Inc (NASDAQ: ALRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Akari Therapeutics PLC (NASDAQ: AKTX ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Akero Therapeutics Inc (NASDAQ: AKRO ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc.
   FB, TSCO among premarket losers  2020/01/30 14:17:56 Seeking Alpha
Sundial Growers (NASDAQ:SNDL) -26% on CEO exit. Briggs & Stratton (NYSE:BGG) -16% on Q2 earnings. Intelsat (NYSE:I) -15%. Albireo Pharma (NASDAQ:ALBO) -10%
   The Daily Biotech Pulse: AstraZeneca Pauses Coronavirus Vaccine Study, Trillium To Get $25M Pfizer Investment  2020/09/09 11:23:14 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Akouos Inc (NASDAQ: AKUS ) Albireo Pharma Inc (NASDAQ: ALB )(announced positive Phase 3 results for odevixibat in a liver disorder called progressive familial intrahepatic cholestasis) Castle Biosciences Inc (NASDAQ: CSTL ) Harmony Biosciences Holdings Inc (NASDAQ: HRMY ) Kura Oncology Inc (NASDAQ: KURA ) Merit Medical Systems, Inc. (NASDAQ: MMSI )(announced sale of manufacturing equipment and associated assets used in its hypotube manufacturing business) X T L Biopharmaceuticals Ltd (NASDAQ: XTLB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 8) ADiTx Therapeutics Inc (NASDAQ: ADTX ) AEterna Zentaris Inc. (NASDAQ: AEZS )(announced the presentation of data from pediatric study of macimorelin for childhood-onset growth hormone deficiency) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) Ayala Pharmaceuticals Inc (NASDAQ: AYLA ) Burning Rock Biotech Ltd (NASDAQ: BNR ) Checkmate Pharmaceuticals Inc (NASDAQ: CMPI ) Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP )( reacted to a negative data readout) Immatics NV (NASDAQ: IMTX ) Kymera Therapeutics Inc (NASDAQ: KYMR ) Legend Biotech Corp (NASDAQ: LEGN ) Regulus Therapeutics Inc (NASDAQ: RGLS ) Royalty Pharma plc (NASDAQ: RPRX ) Second Sight Medical Products Inc (NASDAQ: EYES ) Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS ) Viveve Medical Inc (NASDAQ: VIVE ) Stocks In Focus AstraZeneca Halts Coronavirus Vaccine Study to Allow For Safety Review Following an Unexplained Illness AstraZeneca plc (NYSE: AZN ) shares are under pressure after the company said in a statement to STATNews it has voluntarily paused the study of the coronavirus vaccine candidate it is jointly developing with the Oxford University in order to allow review of safety data by an independent committee.
   32 Stocks Moving in Tuesday's Pre-Market Session  2020/09/08 11:12:58 Benzinga
Gainers Albireo Pharma, Inc. (NASDAQ: ALBO ) rose 66.2% … Full story available on Benzinga.com
   The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings  2020/03/13 11:52:53 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo Corporation (NASDAQ: MASI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 12.) Abbott Laboratories (NYSE: ABT ) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Aileron Therapeutics Inc (NASDAQ: ALRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Akari Therapeutics PLC (NASDAQ: AKTX ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Akero Therapeutics Inc (NASDAQ: AKRO ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc.
   FB, TSCO among premarket losers  2020/01/30 14:17:56 Seeking Alpha
Sundial Growers (NASDAQ:SNDL) -26% on CEO exit. Briggs & Stratton (NYSE:BGG) -16% on Q2 earnings. Intelsat (NYSE:I) -15%. Albireo Pharma (NASDAQ:ALBO) -10%
   Were Hedge Funds Right About Souring On Albireo Pharma, Inc. (ALBO)?  2019/11/06 19:51:52 Yahoo Finance
The elite funds run by legendary investors such as David Tepper and Dan Loeb make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research on small cap stocks that big investment banks don't follow. Because of their pay structures, they have
   The Daily Biotech Pulse: AstraZeneca Pauses Coronavirus Vaccine Study, Trillium To Get $25M Pfizer Investment  2020/09/09 11:23:14 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Akouos Inc (NASDAQ: AKUS ) Albireo Pharma Inc (NASDAQ: ALB )(announced positive Phase 3 results for odevixibat in a liver disorder called progressive familial intrahepatic cholestasis) Castle Biosciences Inc (NASDAQ: CSTL ) Harmony Biosciences Holdings Inc (NASDAQ: HRMY ) Kura Oncology Inc (NASDAQ: KURA ) Merit Medical Systems, Inc. (NASDAQ: MMSI )(announced sale of manufacturing equipment and associated assets used in its hypotube manufacturing business) X T L Biopharmaceuticals Ltd (NASDAQ: XTLB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 8) ADiTx Therapeutics Inc (NASDAQ: ADTX ) AEterna Zentaris Inc. (NASDAQ: AEZS )(announced the presentation of data from pediatric study of macimorelin for childhood-onset growth hormone deficiency) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) Ayala Pharmaceuticals Inc (NASDAQ: AYLA ) Burning Rock Biotech Ltd (NASDAQ: BNR ) Checkmate Pharmaceuticals Inc (NASDAQ: CMPI ) Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP )( reacted to a negative data readout) Immatics NV (NASDAQ: IMTX ) Kymera Therapeutics Inc (NASDAQ: KYMR ) Legend Biotech Corp (NASDAQ: LEGN ) Regulus Therapeutics Inc (NASDAQ: RGLS ) Royalty Pharma plc (NASDAQ: RPRX ) Second Sight Medical Products Inc (NASDAQ: EYES ) Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS ) Viveve Medical Inc (NASDAQ: VIVE ) Stocks In Focus AstraZeneca Halts Coronavirus Vaccine Study to Allow For Safety Review Following an Unexplained Illness AstraZeneca plc (NYSE: AZN ) shares are under pressure after the company said in a statement to STATNews it has voluntarily paused the study of the coronavirus vaccine candidate it is jointly developing with the Oxford University in order to allow review of safety data by an independent committee.
   32 Stocks Moving in Tuesday's Pre-Market Session  2020/09/08 11:12:58 Benzinga
Gainers Albireo Pharma, Inc. (NASDAQ: ALBO ) rose 66.2% … Full story available on Benzinga.com
   The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings  2020/03/13 11:52:53 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo Corporation (NASDAQ: MASI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 12.) Abbott Laboratories (NYSE: ABT ) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Aileron Therapeutics Inc (NASDAQ: ALRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Akari Therapeutics PLC (NASDAQ: AKTX ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Akero Therapeutics Inc (NASDAQ: AKRO ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc.
   FB, TSCO among premarket losers  2020/01/30 14:17:56 Seeking Alpha
Sundial Growers (NASDAQ:SNDL) -26% on CEO exit. Briggs & Stratton (NYSE:BGG) -16% on Q2 earnings. Intelsat (NYSE:I) -15%. Albireo Pharma (NASDAQ:ALBO) -10%
   Were Hedge Funds Right About Souring On Albireo Pharma, Inc. (ALBO)?  2019/11/06 19:51:52 Yahoo Finance
The elite funds run by legendary investors such as David Tepper and Dan Loeb make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research on small cap stocks that big investment banks don't follow. Because of their pay structures, they have

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 アルビレオ・ファ―マ ALBO Albireo Pharma Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)